Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) - Total Liabilities
Based on the latest financial reports, Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) has total liabilities worth CN¥717.55 Million CNY (≈ $105.00 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 605016 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. - Total Liabilities Trend (2016–2025)
This chart illustrates how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. See 605016 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
LIBERTY LAT.AMER.C DL-01
F:1LLC
|
Germany | €11.16 Billion |
|
Compass Pathways Plc
NASDAQ:CMPS
|
USA | $263.20 Million |
|
Orora Ltd
AU:ORA
|
Australia | AU$1.95 Billion |
|
Formula
TA:FORTY
|
Israel | ILA1.81 Billion |
|
Bomin Electronics Co Ltd
SHG:603936
|
China | CN¥6.13 Billion |
|
Global Brands Manufacture Ltd
TW:6191
|
Taiwan | NT$34.31 Billion |
|
Lanzhou LS Heavy Equipment Co
SHG:603169
|
China | CN¥9.62 Billion |
|
Centuria Industrial REIT
AU:CIP
|
Australia | AU$1.51 Billion |
Liability Composition Analysis (2016–2025)
This chart breaks down Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Shandong Bailong Chuangyuan Bio-Tech Co. worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.51 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.34 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2025)
The table below shows the annual total liabilities of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥475.19 Million ≈ $69.54 Million |
+42.16% |
| 2024-12-31 | CN¥334.27 Million ≈ $48.91 Million |
+35.69% |
| 2023-12-31 | CN¥246.35 Million ≈ $36.05 Million |
+93.99% |
| 2022-12-31 | CN¥126.99 Million ≈ $18.58 Million |
+60.65% |
| 2021-12-31 | CN¥79.05 Million ≈ $11.57 Million |
-45.45% |
| 2020-12-31 | CN¥144.91 Million ≈ $21.20 Million |
-7.87% |
| 2019-12-31 | CN¥157.28 Million ≈ $23.01 Million |
+45.50% |
| 2018-12-31 | CN¥108.09 Million ≈ $15.82 Million |
-42.92% |
| 2017-12-31 | CN¥189.38 Million ≈ $27.71 Million |
-29.64% |
| 2016-12-31 | CN¥269.14 Million ≈ $39.38 Million |
-- |
About Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of food and feed additives in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto-oligosaccharide, galacto-oligosaccharide, and xylo-oligosaccharide. It also provides starch sugars comprising allulose, maltit… Read more